Biopharmaceuticals. Official position of Russian Association of Endocrinologists
Some of the glucose-lowering drugs are biopharmaceuticals. This letter states the official position of the Russian Associationof Endocrinologists about the treatment with biopharmaceuticals of patients with endocrine disorders. This topic has not yet been adequately reflected in the legal regulation...
Main Author: | Editorial team Diabetes Mellitus |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2013-11-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://dia-endojournals.ru/dia/article/viewFile/830/469 |
Similar Items
-
Russian Association of Endocrinologists about the introduction of Diabeton MR (60 mg tablets)
by: Editorial team Diabetes Mellitus
Published: (2011-06-01) -
Russian Association of Endocrinologists reports commencement of Trajenta clinical use
by: Editorial team Diabetes Mellitus
Published: (2012-12-01) -
Anniversary of Russian association of endocrinologists
by: Natalya Pavlovna Makolina
Published: (2015-03-01) -
Russian Association of Endocrinologists expert consensus document on initiation and intensification of antyhyperglycaemic therapyin type 2 diabetes mellitus
by: Ivan Ivanovich Dedov, et al.
Published: (2011-12-01) -
Management of prolactinoma: a survey of endocrinologists in China
by: Lijin Ji, et al.
Published: (2018-10-01)